Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate, also known as medroxyprogesterone acetate, is a synthetic progestin hormone commonly used in hormonal birth control methods such as the birth control pill. This medication plays a crucial role in family planning and women’s health by preventing ovulation and thickening cervical mucus to inhibit sperm entry into the uterus. Additionally, medroxyprogesterone acetate is prescribed for various other medical conditions including endometriosis, abnormal uterine bleeding, and hormone replacement therapy in menopausal women. Its significance in everyday life lies in its contribution to reproductive health and overall well-being for many individuals.
Table of Contents:
- 💡 Commercial Applications
- ⚗️ Chemical & Physical Properties
- 🏭 Production & Procurement
- ⚠️ Safety Considerations
- 🔬 Potential Research Directions
- 🧪 Related Compounds
💡 Commercial Applications
Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate, commonly known as cyclofenil, is a synthetic estrogen compound with various commercial and industrial applications. It is used in the pharmaceutical industry for the synthesis of estrogenic medications and hormone replacement therapies. In addition, cyclofenil is utilized in research laboratories for studies related to estrogen receptor modulation and hormonal effects.
In the commercial sector, cyclofenil is employed in the production of estrogen-based products such as contraceptives, menopausal hormone therapies, and fertility treatments. Its estrogenic properties make it a valuable ingredient in formulations designed to regulate hormonal imbalances and reproductive health issues in both men and women. The compound’s ability to interact with estrogen receptors in the body enables it to be utilized in the development of specialized medications for various medical conditions.
As a drug, cyclofenil is primarily utilized for its estrogen-like effects on the endocrine system. It is prescribed for the treatment of conditions such as amenorrhea, oligomenorrhea, and other menstrual irregularities. The compound’s ability to stimulate the production of estrogen in the body is beneficial in cases where hormonal imbalances need to be corrected. Additionally, cyclofenil has been investigated for its potential use in fertility treatments and reproductive health management.
⚗️ Chemical & Physical Properties
Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate is a white solid with no distinct odor.
The molar mass of Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate is approximately 394.55 g/mol, and it has a density of around 1.14 g/cm³. In comparison, common food items like sugar have a molar mass of approximately 342.3 g/mol and a density of around 1.59 g/cm³.
The melting point of Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate is approximately 112-113°C, while the boiling point is around 457-458°C. In contrast, common food items like butter have a melting point of approximately 32-35°C and a boiling point of around 250°C.
Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate is insoluble in water and has a low viscosity. This differs from common food items like salt, which is highly soluble in water, and honey, which has a high viscosity.
🏭 Production & Procurement
Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate, a hormonal medication commonly known as Medroxyprogesterone acetate, is typically produced through a multistep chemical synthesis process in pharmaceutical manufacturing facilities. This process involves the synthesis of the parent compound, followed by the introduction of the required chemical groups to form the final product. Quality control measures are implemented at each stage to ensure purity and efficacy of the end product.
Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate can be procured from pharmaceutical companies or licensed distributors who specialize in the production and distribution of hormonal medications. It is typically available in the form of tablets, injections, or implants, depending on the prescribed dosage and route of administration. Transportation of this medication is carried out in compliance with industry regulations to ensure safety and efficacy during transit to healthcare facilities and pharmacies.
Once Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate reaches its destination, healthcare professionals can prescribe it to patients for various medical conditions, such as hormone replacement therapy, menstrual disorders, or contraception. Patients can obtain this medication from licensed pharmacies with a valid prescription from a healthcare provider. Storage and handling guidelines provided by the manufacturer should be followed to maintain the stability and effectiveness of the product.
⚠️ Safety Considerations
Safety considerations for Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate involve proper handling to avoid skin or eye contact. It is important to wear appropriate personal protective equipment, such as gloves and goggles, when working with this compound. Additionally, it should be stored in a cool, dry place away from sources of ignition to prevent fire hazards.
Hazard statements for Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate include potential skin and eye irritation upon contact. Ingestion or inhalation of this compound may cause harm, and it should be kept away from children and pets. It is also important to avoid releasing it into the environment as it may have adverse effects.
Precautionary statements for Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate recommend using the compound in a well-ventilated area to minimize inhalation exposure. In case of skin contact, wash the affected area with soap and water, and seek medical attention if irritation persists. It is also advised to dispose of any unused or expired compound according to local regulations to avoid environmental contamination.
🔬 Potential Research Directions
One potential research direction for Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate could be its impact on hormonal balance and receptor activation in a biological system. Studies could investigate how this compound interacts with estrogen receptors and its potential as a hormone replacement therapy or in the treatment of hormonal imbalances.
Another avenue of research could focus on the pharmacokinetics and metabolism of Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate. Understanding how the compound is absorbed, distributed, metabolized, and excreted in the body can provide valuable insights into its potential therapeutic applications and safety profile.
Furthermore, research on the potential therapeutic effects of Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate in conditions such as menopausal symptoms, osteoporosis, or certain types of cancer could be pursued. Investigating the compound’s efficacy and side effects in preclinical and clinical studies could contribute to the development of novel treatments in these areas.
🧪 Related Compounds
One similar compound to Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate based upon molecular structure is Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-phenylpropanoate. In this compound, the cyclopentane ring in Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate is replaced with a phenyl group, resulting in a slightly different molecular shape and properties.
Another similar compound to Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate is Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclohexanepropanoate. Here, the cyclopentane ring in Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate is replaced with a cyclohexane ring, leading to changes in the three-dimensional structure and potentially altering the compound’s biological activity.
Additionally, Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-isopropylpropanoate is another similar compound to Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate. In this compound, the cyclopentane ring is retained, but the propanoate group is attached to an isopropyl instead of a cyclopentyl group, resulting in variations in chemical properties and potential biological effects.
